Mirtazapine Zydus (Mirtazapine)

Mirtazapine works by blocking presynaptic α2‑adrenergic receptors, which increases the release of norepinephrine and serotonin. It also antagonizes postsynaptic 5‑HT2 and 5‑HT3 receptors and strongly blocks H1 histamine receptors, producing antidepressant, sedative, and appetite‑stimulating effects.

The appropriate dose of mirtazapine is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and tolerability. Dosage may start at a low level and be adjusted as needed; patients should follow the specific instructions provided by their healthcare professional.

Safety data for mirtazapine in pregnancy and lactation are limited. The drug should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers will evaluate each case individually and discuss potential risks and alternatives.

To order Mirtazapine Zydus, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mirtazapine differs from SSRIs in its mechanism; it enhances both norepinephrine and serotonin release and blocks several serotonin receptors, while also providing strong antihistamine activity. This can result in greater sedation and appetite stimulation, which may be advantageous for patients with insomnia or weight loss, but less suitable for those who need to avoid sedation.

Mirtazapine Zydus should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and excessive heat. Do not store in a refrigerator or freezer unless specifically instructed by the supplier.

Mirtazapine Zydus is administered orally, usually as a tablet or capsule, and taken with or without food as directed by a healthcare professional. Patients should swallow the dosage form whole and avoid crushing or chewing unless the prescriber advises otherwise.

Serious risks include the development of agranulocytosis or severe neutropenia, seizures, emergence or worsening of suicidal thoughts especially early in treatment, and severe hypersensitivity reactions such as Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience signs of infection, unusual mood changes, or severe skin reactions.

Mirtazapine is contraindicated in individuals who have a known hypersensitivity to the drug or any of its components. It should also be avoided in patients currently taking monoamine oxidase inhibitors (MAOIs) or those who have experienced severe adverse reactions to similar antidepressants. Clinicians must assess each patient’s medical history before prescribing.